IRADIMED Names John F. Glenn Chief Financial Officer
iRadimed Corporation (IRMD)
Last iradimed corporation earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
iradimed.com/en-us/investors/investor-contact
Company Research
Source: GlobeNewswire
WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and finance, including business planning and modeling, organizational resource planning, investor and analyst relations, and required reporting and related filings with the SEC. Mr. Glenn, 60, is a Financial Executive with over 30 years’ experience directing corporate finance activities of public and private companies with an established record in significantly growing enterprise value. Mr. Glenn comes to IRADIMED from Esko Bionics Holdings, Inc., a developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Prior to serving as Chief Financial Officer at Esko Bionics, Mr. Glenn served as Chief Financial
Show less
Read more
Impact Snapshot
Event Time:
IRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRMD alerts
High impacting iRadimed Corporation news events
Weekly update
A roundup of the hottest topics
IRMD
News
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2ndGlobeNewswire
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Capital.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $65.00 price target on the stock.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Singular Research.MarketBeat
- IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? [Yahoo! Finance]Yahoo! Finance
IRMD
Earnings
- 2/8/24 - Beat
IRMD
Sec Filings
- 4/3/24 - Form S-3
- 3/1/24 - Form 10-K
- 2/13/24 - Form SC
- IRMD's page on the SEC website